Citation: Hp. Marti et al., FLUOROQUINOLONES AS A CAUSE OF TENDON DISORDERS IN PATIENTS WITH RENAL-FAILURE RENAL-TRANSPLANTS, British journal of rheumatology, 37(3), 1998, pp. 343-344
Authors:
KRAYENBUHL JC
OESTREICHER MK
SIEVERING J
STOLLER R
DAYER P
Citation: Jc. Krayenbuhl et al., RETROSPECTIVE STUDY OF DRUG-INDUCED AGRAN ULOCYTOSIS CASES HOSPITALIZED IN GENEVA COMPARED WITH CASES NOTIFIED TO THE IOCM, Schweizerische medizinische Wochenschrift, 128(6), 1998, pp. 199-202
Citation: R. Stoller, URABA - REGION, ACTORS AND CONFLICT, 1960-1990 - SPANISH - GARCIA,CI, The Hispanic American historical review, 78(2), 1998, pp. 360-361
Citation: K. Corr et R. Stoller, ADVERSE DRUG EVENT REPORTING AT VETERANS AFFAIRS FACILITIES, American journal of health-system pharmacy, 53(3), 1996, pp. 314-315
Citation: F. Cattaneo et al., FLUOROQUINOLONE ASSOCIATED TENDON-RUPTURE AND BILATERAL TENDINITIS INA HEMODIALYSIS PATIENT AND 2 RENAL-TRANSPLANT RECIPIENTS, Kidney international, 50(4), 1996, pp. 1429-1429
Citation: C. Ciorciaro et al., COUMARIN-INDUCED HEPATIC-INJURY - EXPERIE NCE OF SWISS DRUG-MONITORING CENTERS SANZ AND IKS, Schweizerische medizinische Wochenschrift, 126(49), 1996, pp. 2109-2113
Authors:
CRAWFORD J
OZER H
STOLLER R
JOHNSON D
LYMAN G
TABBARA I
KRIS M
GROUS J
PICOZZI V
RAUSCH G
SMITH R
GRADISHAR W
YAHANDA A
VINCENT M
STEWART M
GLASPY J
Citation: J. Crawford et al., REDUCTION BY GRANULOCYTE-COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER, Clinical infectious diseases, 18, 1994, pp. 190000189-190000196
Authors:
MAMOUNAS EP
ANDERSON S
WICKERHAM DL
CLARK R
STOLLER R
HAMM JT
STEWART JA
BEAR HD
GLASS AG
BORNSTEIN R
FISHER B
Citation: Ep. Mamounas et al., THE EFFICACY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PERMITTING THE ADMINISTRATION OF HIGHER DOSES OF CYCLOPHOSPHAMIDE IN A DOXORUBICIN-CYCLOPHOSPHAMIDE COMBINATION - AN NSABP PILOT-STUDY IN PATIENTS WITH METASTATIC OR HIGH-RISK PRIMARY BREAST-CANCER, American journal of clinical oncology, 17(5), 1994, pp. 374-381
Authors:
GLASPY JA
BLEECKER G
CRAWFORD J
STOLLER R
STRAUSS M
Citation: Ja. Glaspy et al., THE IMPACT OF THERAPY WITH FILGRASTIM (RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR) ON THE HEALTH-CARE COSTS ASSOCIATED WITH CANCER-CHEMOTHERAPY, European journal of cancer, 29A, 1993, pp. 23-30